Menu

能倍乐 思力华噻托溴铵的价格贵吗

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

At present, bronchodilators have become the core drugs for the treatment of stable COPD. The existing long-acting inhaled bronchodilators include anticholinergics and β2 receptor agonists. Tiotropium bromide is a classic drug for the treatment of stable COPD. It was developed by Boehringer Ingelheim and is mainly used clinically for the treatment of chronic obstructive pulmonary disease (COPD).

Respimat Tiotropium is a specific and selective anticholinergic drug. The recommended dose is two sprays once a day. The effect of Respimat lasts for 24 hours, and patients are advised not to overdose. Respimat should be used at the same time every day, and, since COPD is a long-term disease, patients can use it every day, not just when they experience breathing problems.

In the human airway, Respimat, Slava, Tiotropium bromide has a high affinity with receptors, and dissociates slowly from muscarinic M1 and M3 receptors, which can block cholinergic nerve-mediated contraction of bronchial smooth muscle for a long time. However, Respimat and Tiotropium dissociate from muscarinic M2 receptors quite quickly, thus showing unique kinetic selectivity for M1 and M3 receptors.

In clinical trials, 298 patients with chronic obstructive pulmonary disease were included in a research trial and were randomly divided into an observation group (149 cases) and a control group (149 cases). The observation group was treated with Respimat, Slivar and tiotropium bromide for 3 months, and the control group was treated with aminophylline for 3 months. The results showed that the lung function increase index of patients treated with Respimat, Slava and Tiotropium was significantly better than that of the control group, and the difference was statistically significant.

The effect of Tiotropium Bromide is good, and the current price is not particularly high. It is around 170$. The price may change due to various factors such as exchange rates. If patients have needs, they can consult the medical companion and travel service for specific information.

Recommended related hot articles: /newsDetail/85138.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。